VRB-101
EVOLVE-2
Verdiva Bio Dev Limited · Phase 2 · Completed · Enrollment 206
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Schedule A: VRB-101 (Active Arm 1) | n/r | n/r | n/r | n/r | n/r |
| Schedule A: VRB-101 (Active Arm 2) | n/r | n/r | n/r | n/r | n/r |
| Schedule A: VRB-101 (Active Arm 3) | n/r | n/r | n/r | n/r | n/r |
| Schedule B: VRB-101 (Active Arm 4) | n/r | n/r | n/r | n/r | n/r |
| Schedule B: VRB-101 (Active Arm 5) | n/r | n/r | n/r | n/r | n/r |
| Pooled Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.